Cell Therapeutics Fails To Nix Investor Class Action

Law360, New York (February 7, 2011, 5:24 PM EST) -- A federal judge has refused to dismiss a consolidated class action accusing biopharmaceutical company Cell Therapeutics Inc. and its executives of misleading investors into believing the U.S. Food and Drug Administration was poised to approve a new cancer treatment product.

In an order filed Friday in the U.S. District Court for the Western District of Washington, Judge Marsha J. Pechman rejected CTI's arguments for dismissal, saying the plaintiffs have provided enough circumstantial evidence to sufficiently allege scienter on the part of the company and its executives....
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Sabbagh v. Cell Therapeutics Inc et al


Case Number

2:10-cv-00414

Court

Washington Western

Nature of Suit

Securities/Commodities

Judge

Marsha J. Pechman

Date Filed

March 12, 2010

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.